tiprankstipranks
Trending News
More News >
Cue Biopharma Inc (CUE)
NASDAQ:CUE
US Market

Cue Biopharma (CUE) Financial Statements

Compare
629 Followers

Cue Biopharma Financial Overview

Cue Biopharma's market cap is currently $35.85M. The company's EPS TTM is $-0.07; its P/E ratio is -0.86; Cue Biopharma is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.10. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 9.29M$ 5.49M$ 1.25M$ 14.94M$ 3.15M
Gross Profit$ 9.29M$ -32.61M$ 1.25M$ 16.72M$ -30.39M
Operating Income$ -41.50M$ -52.15M$ -53.23M$ -43.71M$ -45.04M
EBITDA$ -37.53M$ -46.05M$ -50.49M$ -45.44M$ -43.99M
Net Income$ -40.67M$ -50.73M$ -53.01M$ -44.16M$ -44.78M
Balance Sheet
Cash & Short-Term Investments$ 23.39M$ 48.51M$ 76.29M$ 64.37M$ 84.87M
Total Assets$ 32.19M$ 61.53M$ 91.28M$ 83.40M$ 99.53M
Total Debt$ 8.88M$ 14.70M$ 19.32M$ 12.02M$ 7.15M
Net Debt$ -13.58M$ -33.82M$ -32.30M$ -52.35M$ -67.72M
Total Liabilities$ 14.69M$ 24.45M$ 25.60M$ 17.91M$ 20.62M
Stockholders' Equity$ 17.50M$ 37.09M$ 65.68M$ 65.49M$ 78.91M
Cash Flow
Free Cash Flow$ -36.40M$ -39.96M$ -41.98M$ -39.75M$ -33.09M
Operating Cash Flow$ -36.33M$ -39.96M$ -41.81M$ -38.84M$ -32.49M
Investing Cash Flow$ 32.00K$ 25.00M$ -24.61M$ 9.11M$ 4.46M
Financing Cash Flow$ 10.24M$ 11.86M$ 53.66M$ 19.23M$ 58.61M
Currency in USD

Cue Biopharma Earnings and Revenue History

Cue Biopharma Debt to Assets

Cue Biopharma Cash Flow

Cue Biopharma Forecast EPS vs Actual EPS